1. Home
  2. VECO vs ANIP Comparison

VECO vs ANIP Comparison

Compare VECO & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veeco Instruments Inc.

VECO

Veeco Instruments Inc.

HOLD

Current Price

$30.22

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$74.40

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VECO
ANIP
Founded
1945
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
VECO
ANIP
Price
$30.22
$74.40
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$27.25
$107.33
AVG Volume (30 Days)
1.1M
324.0K
Earning Date
05-28-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
0.59
3.32
Revenue
$664,294,000.00
$206,547,000.00
Revenue This Year
$18.35
$19.88
Revenue Next Year
$12.86
$15.77
P/E Ratio
$53.91
$22.77
Revenue Growth
N/A
2.47
52 Week Low
$16.92
$56.71
52 Week High
$35.77
$99.50

Technical Indicators

Market Signals
Indicator
VECO
ANIP
Relative Strength Index (RSI) 47.41 39.18
Support Level $27.79 $62.89
Resistance Level $33.48 $85.12
Average True Range (ATR) 1.74 2.65
MACD 0.14 -0.07
Stochastic Oscillator 44.70 23.01

Price Performance

Historical Comparison
VECO
ANIP

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The maximum of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: